| Tumor Microenvironment in Prostate Cancer: Toward Identification of Novel Molecular Biomarkers for Diagnosis, Prognosis, and Therapy Development HF Bahmad, M Jalloul, J Azar, MM Moubarak, TA Samad, D Mukherji, ... Frontiers in Genetics 12, 472, 2021 | 74 | 2021 |
| The Use of Stem Cell-Derived Organoids in Disease Modeling: An Update J Azar, HF Bahmad, D Daher, MM Moubarak, O Hadadeh, A Monzer, ... International Journal of Molecular Sciences 22 (14), 7667, 2021 | 72 | 2021 |
| Modeling Adipogenesis: Current and Future Perspective HF Bahmad, R Daouk, J Azar, J Sapudom, J Teo, W Abou-Kheir, ... Cells 9 (10), 2326, 2020 | 66 | 2020 |
| HTR-8/SVneo: A model for epithelial to mesenchymal transition in the human placenta H Msheik, J Azar, M El Sabeh, W Abou-Kheir, G Daoud Placenta 90, 90-97, 2020 | 60 | 2020 |
| Transcriptomic profiling of trophoblast fusion using BeWo and JEG-3 cell lines H Msheik, S El Hayek, MF Bari, J Azar, W Abou-Kheir, F Kobeissy, ... Molecular human reproduction 25 (12), 811-824, 2019 | 29 | 2019 |
| Phase I Trial Characterizing the Pharmacokinetic Profile of N-803, a Chimeric IL-15 Superagonist, in Healthy Volunteers MP Rubinstein, C Williams, C Mart, J Beall, L MacPherson, J Azar, ... The Journal of Immunology 208 (6), 1362-1370, 2022 | 16 | 2022 |
| Converting Tumoral PD-L1 into a 4-1BB Agonist for Safer and More Effective Cancer Immunotherapy Z Li, JH Azar, MP Rubinstein Cancer Discovery 12 (5), 1184-1186, 2022 | 5 | 2022 |
| Cancerona: challenges of cancer management in times of COVID-19 pandemic F Ballout, R Daouk, J Azar, M Timonian, T Araji, HF Bahmad, ... SN Comprehensive Clinical Medicine 2, 2005-2014, 2020 | 4 | 2020 |
| Selective suppression of de novo SARS-CoV-2 vaccine antibody responses in patients with cancer on B cell–targeted therapy JH Azar, JP Evans, MH Sikorski, KB Chakravarthy, S McKenney, ... JCI insight 8 (6), 2023 | 2 | 2023 |
| Translational and oncologic significance of tertiary lymphoid structures in pancreatic adenocarcinoma Z Gao, J Azar, H Zhu, S Williams-Perez, SW Kang, C Marginean, ... Frontiers in Immunology 15, 1324093, 2024 | 1 | 2024 |
| Phase I trial characterizing the pharmacokinetic profile and NK and CD8+ t cell expansion with n-803, a chimeric IL-15 superagonist, in healthy volunteers. JM Wrangle, MP Rubinstein, C Mart, JH Azar, C Williams, ... Journal of Clinical Oncology 38 (15_suppl), e15008-e15008, 2020 | 1 | 2020 |
| Ovarian cancer in the Arab world: An updated review J Azar, T Kaddoura, MA Timonian, ES Karam, W Abou-Kheir, G Daoud Gene Reports, 102025, 2024 | | 2024 |
| Cardiac differentiation is modulated by anti-apoptotic signals in murine embryonic stem cells A Yehya, J Azar, M Al-Fares, H Boeuf, W Abou-Kheir, D Zeineddine, ... World Journal of Stem Cells 16 (5), 551, 2024 | | 2024 |
| Pre-treatment inflamed tumor immune microenvironment is associated with FOLFIRINOX response in pancreatic cancer Z Gao, SW Kang, D Erstad, J Azar, G Van Buren, W Fisher, Z Sun, ... Frontiers in Oncology 13, 1274783, 2023 | | 2023 |
| Flow of Medication Supply and Funds to Examine Access to the Lebanese Healthcare System after the Collapse of the Subsidy System: A Macro to Micro Overview R Kakati, J Azar, M Mansour, A Kalousdian, M Reda, R Zeitoun, D Daou, ... OSF Preprints, 2023 | | 2023 |
| WJSC A Yehya, J Azar, M Al-Fares, H Boeuf, W Abou-Kheir, D Zeineddine, ... | | 2023 |
| Suppression of de novo antibody responses against SARS-CoV2 and the Omicron variant after mRNA vaccination and booster in patients with B cell malignancies undergoing active … J Azar, JP Evans, M Sikorski, K Chakravarthy, S McKenney, I Carmody, ... medRxiv, 2022.03. 17.22272389, 2022 | | 2022 |